share_log

Chemed Insiders Sold US$23m Of Shares Suggesting Hesitancy

Chemed Insiders Sold US$23m Of Shares Suggesting Hesitancy

Chemed Insiders出售了2300萬美元的股票,這表明他們猶豫不決
Simply Wall St ·  02/02 08:49

In the last year, many Chemed Corporation (NYSE:CHE) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When evaluating insider transactions, knowing whether insiders are buying versus if they selling is usually more beneficial, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

去年,許多Chemed Corporation(紐約證券交易所代碼:CHE)內部人士出售了該公司的大量股份,這可能引起了股東的關注。在評估內幕交易時,了解內部人士是買入還是賣出通常更有利,因爲後者可能有多種解釋。但是,當多個內部人士在特定期限內出售股票時,股東應注意,因爲這可能是一個危險信號。

While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.

儘管在長期投資方面,內幕交易並不是最重要的事情,但我們確實認爲密切關注內部人士的所作所爲是完全合乎邏輯的。

Chemed Insider Transactions Over The Last Year

去年的Chemed內幕交易

Over the last year, we can see that the biggest insider sale was by the insider, David Williams, for US$3.5m worth of shares, at about US$584 per share. That means that an insider was selling shares at slightly below the current price (US$598). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. We note that the biggest single sale was only 27% of David Williams's holding.

在過去的一年中,我們可以看到,最大的內幕出售是知情人大衛·威廉姆斯以每股約584美元的價格出售了價值350萬美元的股票。這意味着一位內部人士正在以略低於當前價格(598美元)的價格出售股票。如果內部人士一直在賣出,特別是如果他們賣出低於當前價格,我們通常認爲這是負面的,因爲這意味着他們認爲較低的價格是合理的。儘管內幕拋售不是一個積極的信號,但我們無法確定這是否意味着內部人士認爲股票已完全估值,因此這只是一個弱勢信號。我們注意到,最大的單筆交易僅佔大衛·威廉姆斯持股量的27%。

In the last year Chemed insiders didn't buy any company stock. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

去年,Chemed內部人士沒有購買任何公司股票。下圖顯示了去年的內幕交易(公司和個人)。如果你想確切地知道誰賣了、賣了多少以及何時出售,只需點擊下圖!

insider-trading-volume
NYSE:CHE Insider Trading Volume February 2nd 2024
紐約證券交易所:CHE 內幕交易量 2024 年 2 月 2 日

I will like Chemed better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

如果我看到一些重大的內幕收購,我會更喜歡Chemed。在我們等待的同時,請查看這份免費清單,列出了最近有大量內幕收購的成長型公司。

Chemed Insiders Are Selling The Stock

Chemed Insiders 正在出售這隻股票

The last quarter saw substantial insider selling of Chemed shares. In total, insiders sold US$11m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

上個季度,Chemed股票出現了大量內幕拋售。在此期間,內部人士總共出售了價值1100萬美元的股票,我們沒有記錄任何購買記錄。有鑑於此,很難說所有內部人士都認爲股票很划算。

Insider Ownership Of Chemed

Chemed 的內部所有權

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. Chemed insiders own 1.9% of the company, currently worth about US$173m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

許多投資者喜歡檢查一家公司有多少股份由內部人士擁有。我們通常希望看到相當高的內部所有權水平。Chemed內部人士擁有該公司1.9%的股份,根據最近的股價,目前價值約1.73億美元。我喜歡看到這種程度的內部所有權,因爲它增加了管理層考慮股東最大利益的機會。

So What Do The Chemed Insider Transactions Indicate?

那麼,Chemed的內幕交易表明了什麼?

Insiders haven't bought Chemed stock in the last three months, but there was some selling. And there weren't any purchases to give us comfort, over the last year. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Chemed. While conducting our analysis, we found that Chemed has 1 warning sign and it would be unwise to ignore this.

內部人士在過去三個月中沒有買入Chemed的股票,但出現了一些拋售。在過去的一年裏,沒有任何能讓我們感到安慰的購買。該公司擁有很高的內部所有權,但考慮到股票銷售的歷史,我們有點猶豫。除了了解正在進行的內幕交易外,確定Chemed面臨的風險也是有益的。在進行分析時,我們發現Chemed有1個警告信號,忽略這一點是不明智的。

But note: Chemed may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:Chemed可能不是最值得購買的股票。因此,來看看這份投資回報率高、債務低的有趣公司的免費清單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論